# To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients

> **NCT03443804** · PHASE3 · COMPLETED · sponsor: **Daewon Pharmaceutical Co., Ltd.** · enrollment: 462 (actual)

## Conditions studied

- Gastritis Acute
- Gastritis Chronic

## Interventions

- **DRUG:** Test(DW1401)
- **DRUG:** Reference(Stillen tab.)

## Key facts

- **NCT ID:** NCT03443804
- **Lead sponsor:** Daewon Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 462 (ACTUAL)
- **Last updated:** 2018-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03443804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03443804, "To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03443804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*